Tenosynovial Giant Cell Tumor — Trials

Tenosynovial Giant Cell Tumor — Trials · CancerIndex

Clinical trials

Registered studies

25 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–5 of 5 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07499362	Study of Pimicotinib in Japanese Participants With Tenosynovial Giant Cell Tumor (TGCT) (J-MANEUVER)	recruiting	Phase 2	20	Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, GermanyINDUSTRY	1	Sep 10, 2026	clinicaltrials
NCT07075471	MOVE: Tenosynovial Giant Cell Tumor (TGCT) Real-World Participant Experience With Vimseltinib(MOVE)	recruiting	—	100	Deciphera Pharmaceuticals, LLCINDUSTRY	1	Jul 27, 2026	clinicaltrials
NCT04192344	A Study to Assess the Safety, Tolerability, and Pharmacokinetics of ABSK-021 in Patients With Advanced Solid Tumor	recruiting	Phase 1	276	Abbisko Therapeutics Co, LtdINDUSTRY	2	Mar 19, 2026	clinicaltrials

Data updated 20 days agoSource updated Sep 10, 2026source: clinicaltrials